Ep 2. Hash

In season 2 episode 2 of Drugs, Inc., viewers are taken on a journey through the world of hash. From the mountains of Lebanon to the streets of New York City, the episode explores the production, distribution, and use of this popular form of cannabis.

The episode begins by introducing the viewers to the traditional methods used to create hash in Lebanon. Farmers gather the large cannabis plants, which are then beaten with sticks to separate the resin from the rest of the plant. The resin is then pressed into small bricks, which are sold around the world for various purposes.

From there, the focus shifts to the impact of hash on the streets of New York City. Viewers meet a group of young men who sell the drug in local parks, and learn about the dangerous risks they face in doing so. The men talk about the profits they can make from selling the drug, but also acknowledge the risks of arrest and violence.

The episode also explores the medical benefits of hash, with interviews from doctors and patients who have used the drug to manage chronic pain and other medical conditions. One patient shares her story about using hash as part of her breast cancer treatment, and the relief it brought her during a difficult time.

Throughout the episode, viewers learn about the different types and qualities of hash, and how they impact the user's experience. From traditional Lebanese hash to newer, more potent forms created in labs, the episode covers the wide range of options available to users.

The episode also highlights the dangers of using hash, such as addiction, impaired driving, and damage to the lungs. Experts discuss the need for further research into the drug to fully understand its impacts on the body and mind.

Overall, season 2 episode 2 of Drugs, Inc. offers a detailed look at the world of hash and its impact on individuals and society as a whole. Through interviews with experts, users, and sellers, viewers gain a better understanding of the drug and the complexities surrounding its use and distribution.